329 related articles for article (PubMed ID: 22111871)
1. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
[TBL] [Abstract][Full Text] [Related]
2. Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage.
Nagamachi S; Ohsawa I; Suzuki H; Sato N; Inoshita H; Hisada A; Honda D; Shimamoto M; Shimizu Y; Horikoshi S; Tomino Y
BMC Nephrol; 2014 May; 15():82. PubMed ID: 24885016
[TBL] [Abstract][Full Text] [Related]
3. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.
Wen L; Zhao Z; Wang Z; Xiao J; Birn H; Gregersen JW
Nephrology (Carlton); 2019 Jul; 24(7):703-710. PubMed ID: 30141239
[TBL] [Abstract][Full Text] [Related]
4. Complement activation is associated with crescent formation in IgA nephropathy.
Itami H; Hara S; Samejima K; Tsushima H; Morimoto K; Okamoto K; Kosugi T; Kawano T; Fujiki K; Kitada H; Hatakeyama K; Tsuruya K; Ohbayashi C
Virchows Arch; 2020 Oct; 477(4):565-572. PubMed ID: 32300880
[TBL] [Abstract][Full Text] [Related]
5. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.
Endo M; Fuke Y; Tamano M; Hidaka M; Ohsawa I; Fujita T; Ohi H
Nephron Clin Pract; 2004; 97(4):c147-53. PubMed ID: 15331938
[TBL] [Abstract][Full Text] [Related]
6. Complement Activation Is Associated With Crescents in IgA Nephropathy.
Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
Front Immunol; 2021; 12():676919. PubMed ID: 34594322
[TBL] [Abstract][Full Text] [Related]
7. The role of complement activation, detected by urinary C5b-9 and urinary factor H, in the excretion of urinary albumin in cisplatin nephropathy.
Fuke Y; Fujita T; Satomura A; Endo M; Matsumoto K
Clin Nephrol; 2009 Feb; 71(2):110-7. PubMed ID: 19203502
[TBL] [Abstract][Full Text] [Related]
8. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
Niu X; Zhang S; Shao C; Guo Z; Wu J; Tao J; Zheng K; Ye W; Cai G; Sun W; Li M
PeerJ; 2023; 11():e15125. PubMed ID: 37065697
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.
Dumont C; Mérouani A; Ducruet T; Benoit G; Clermont MJ; Lapeyraque AL; Phan V; Patey N
Pediatr Nephrol; 2020 May; 35(5):843-850. PubMed ID: 31932958
[TBL] [Abstract][Full Text] [Related]
10. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
[TBL] [Abstract][Full Text] [Related]
11. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.
Machiguchi T; Yoshida H; Yonemoto S; Minakata T; Nomura K; Muso E; Tamura T; Sasayama S
Nephrol Dial Transplant; 1999 Mar; 14(3):635-40. PubMed ID: 10193812
[TBL] [Abstract][Full Text] [Related]
12. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
[TBL] [Abstract][Full Text] [Related]
13. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
Medjeral-Thomas NR; Lomax-Browne HJ; Beckwith H; Willicombe M; McLean AG; Brookes P; Pusey CD; Falchi M; Cook HT; Pickering MC
Kidney Int; 2017 Oct; 92(4):942-952. PubMed ID: 28673452
[TBL] [Abstract][Full Text] [Related]
14. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
16. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
[TBL] [Abstract][Full Text] [Related]
17. Complement activation products in the circulation and urine of primary membranous nephropathy.
Zhang MF; Huang J; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Cui Z; Liu G; Zhao MH
BMC Nephrol; 2019 Aug; 20(1):313. PubMed ID: 31399080
[TBL] [Abstract][Full Text] [Related]
18. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
19. Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics.
Wang D; Wu C; Chen S; Li Y; Wang L; Zhang Y; Li G
Front Immunol; 2023; 14():1117995. PubMed ID: 37020564
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Tasaki Y; Ohta K; Yachie A; Wada T
Pediatr Res; 2021 Feb; 89(3):667-672. PubMed ID: 32408340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
